Skip to content
Search

Latest Stories

'Our future pharmacists deserve better', sector lambasts GPhC for failing foundation exam candidates

The General Pharmaceutical Council has apologized for severe delays and disruptions during the June foundation registration assessment at five test centres in England on Wednesday (June 29).

The pharmacy regulator said it has since "contacted the candidates affected via email to apologise for the disruption and the extra worry this will have caused.


"We will also be issuing our usual survey for all candidates so we can hear directly from them about their experiences and have also asked candidates to get in touch if they would like individual advice."

GPhC admitted that the worse sufferers were the candidates at a test centre in Nottingham "where the delay was severe and candidates were only able to start Paper 1 in the late afternoon".

Extremely sorry

In a statement, Duncan Rudkin, chief executive of the GPhC, said: “We are extremely sorry for the severe delays experienced by candidates in Nottingham today. This is completely unacceptable, and we fully appreciate the significant stress and disruption this must have caused for them in such a high-stakes assessment.

“We are advising the candidates in Nottingham that we will accept the severe delay as grounds for appeal if they do not pass. This means that if they do not pass the assessment, this sitting would not count as one of their attempts to pass. We are considering what else we can do to support the affected candidates.

“The GPhC and BTL will also work together as a priority to review what caused these delays and make sure lessons are learnt to help avoid these issues happening again in the future.”

Nisha's ordeal

A candidate took to Twitter to complain: "Left the Notts #gphcexam at 11pm, was in the building for 14 hrs, sat for 8 hrs in starvation waiting to sit the exam-was made to press end test 30 mins before my exam timer was up because they ‘had to close the building’, didn’t get to read the last 22 questions.

Pharmacy Business has asked GPhC how it will compensate the affected candidates like Nisha.

GPhC has since tried to reach out to Nisha via Twitter -- apologising for her "completely unacceptable experience" and dealing with her case "as a matter of urgency".

The pharmacy regulator says that the majority of the just under 2,700 registration exam candidates "were able to complete the assessment with no issues". Those in five test centres -- of a total of 113 centres across the UK -- "experienced delays in starting either Paper 1 or Paper 2 due to IT or other technical issues".

'We need better systems'

Commenting on the difficulties and delays experienced by candidates in five centres in England, Royal Pharmaceutical Society president Claire Anderson said: “The registration examination is the gateway to our profession. It exists to preserve the profession’s integrity and protect patients, and as such there must be confidence in it. After continued issues over multiple sittings, however, the profession is losing this trust... Our future pharmacists deserve better. The GPhC must ensure no trainee ever has this kind of experience again.”

Senior pharmacist Mohammed Hussain tweeted: "This must just be awful for the candidates. Five years leading to this and then they have to stay quarantined for several hours in a room, stressed, waiting for the the exam to start. These failures keep happening, we need better systems and mitigations.".

Meanwhile, the profession's charity, Pharmacist Support, has offered help to those affected by the exam chaos. "We're sorry to hear of the issues that went on with the registration assessment. Please remember we are here to support you with your wellbeing."

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less